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Abstract
Objective: To develop quality metrics (QMs) for the ambulatory care of patients with transposi-
tion of the great arteries following arterial switch operation (TGA/ASO).
Design: Under the auspices of the American College of Cardiology Adult Congenital and Pediatric
Cardiology (ACPC) Steering committee, the TGA/ASO team generated candidate QMs related to
TGA/ASO ambulatory care. Candidate QMs were submitted to the ACPC Steering Committee and
were reviewed for validity and feasibility using individual expert panel member scoring according
to the RAND-UCLA methodology. QMs were then made available for review by the entire ACC
ACPC during an “open comment period.” Final approval of each QM was provided by a vote of
the ACC ACPC Council.
Patients: Patients with TGA who had undergone an ASO were included. Patients with complex
transposition were excluded.
Results: Twelve candidate QMs were generated. Seven metrics passed the RAND-UCLA process.
Four passed the “open comment period” and were ultimately approved by the Council. These
included: (1) at least 1 echocardiogram performed during the first year of life reporting on the
function, aortic dimension, degree of neoaortic valve insufficiency, the patency of the systemic
and pulmonary outflows, the patency of the branch pulmonary arteries and coronary arteries, (2)
neurodevelopmental (ND) assessment after ASO; (3) lipid profile by age 11 years; and (4) docu-
mentation of a transition of care plan to an adult congenital heart disease (CHD) provider by 18
years of age.
Conclusions: Application of the RAND-UCLA methodology and linkage of this methodology to
the ACPC approval process led to successful generation of 4 QMs relevant to the care of TGA/
ASO pediatric patients in the ambulatory setting. These metrics have now been incorporated into
the ACPC Quality Network providing guidance for the care of TGA/ASO patients across 30 CHD
centers.
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1 | INTRODUCTION
The goal of quality metric (QM) development is to create self assess-
ment measures that can be easily utilized by providers and healthcare
systems. These metrics should address key issues related to patient
management and allow for evidence based care, greater consistency in
care and ultimately, when utilized, lead to improvements in clinical care
and patient outcome.1 Historically, the outpatient management of
children with congenital heart disease (CHD) has varied according to
center and provider preference.2 Consistent and evidence based clini-
cal practice has been limited by the paucity of established guidelines
and the challenge of creating evidence based recommendations given
heterogeneity within the CHD population, even for a single diagnosis
and intervention.
While mortality rates associated with transposition of the great
arteries (TGA) following arterial switch operation (ASO) have improved
over time, patients with TGA/ASO remain at risk for significant
midterm and long-term complications including myocardial ischemia,
left ventricular dysfunction, arrhythmia and sudden cardiac death
(SCD),2–12 neoaortic valve regurgitation (NAR), aortic root dilation
(ARD), supravalvar pulmonary stenosis (SPS), supravalvar aortic stenosis
(SAS),2,13–17 impaired neurodevelopmental (ND) outcome,18–24 and the
development of risk factors for premature atherosclerosis, including
unhealthy weight, elevated blood pressure and high cholesterol.25
Similar to many CHD patients, teenagers with TGA/ASO are vulnerable
to delays in transition of care to an adult provider and lapses in care, as
a result.26,27
To date there have been no established guidelines offering metrics
for quality improvement in the ambulatory care setting for children
with TGA/ASO.2,24–30 Recognizing the need to develop valid and
feasible QM in 5 key areas of pediatric and congenital disease care,
including children with TGA/ASO, the American College of Cardiology
(ACC) Adult Congenital and Pediatric Cardiology Council (ACPC)
proposed use of a 2 step review process, incorporating the modified
RAND-UCLA methodology, for the creation of QMs relevant to the
ambulatory care of TGA/ASO pediatric patients.31 This article outlines
the process utilized to generate QMs, reviews the candidate QMs and
describes the QMs that were ultimately selected for TGA/ASO
patients.
2 | METHODS
Members of the TGA/ASO QM group were members of the ACC and
were selected on a volunteer basis. There were 12 members of the
TGA/ASO group. Members were expected to have content expertise
and to participate in biweekly conference calls. Two to three person
groups were created among the members to divide up the work of
evaluating the existing literature and to create candidate QMs to be
reviewed by the entire team. Each 2–3 person group generated
candidate QMs. Given that the goal was to generate metrics for quality
improvement in ambulatory practice, proposed candidate QMs
included a description of the proposed metric, a numerator (e.g., what
was to be measured from a patient’s chart), a denominator (e.g., the
target population), exclusions, and a summary of the key references
(see Supporting Information Appendix 1). The QMs were designed for
ease of ascertainment of data from a patient’s electronic medical
record (EMR). All resulting QMs were discussed over a series of confer-
ence calls involving the entire TGA/ASO team.
Only QMs relevant to the outpatient management of TGA/ASO
recipients and that addressed risk factors for mid and long term
morbidity and mortality following the ASO procedure were created.
We excluded patients with complex TGA, including those with a
hemodynamically significant ventricular septal defect (VSD), aortic arch
obstruction, or congenitally corrected transposition, to analyze a more
homogenous population. We also excluded TGA patients who had
undergone Mustard or Senning operations.
Candidate QMs were then submitted to the ACC ACPC Steering
Committee for expert panel review. Employing the RAND-UCLA pro-
cess,32 candidate QMs were first individually scored for validity and
feasibility by a single member of the expert panel and then independ-
ently scored by each member of the expert panel during an in-person
meeting of the Steering Committee and expert panel on October 3 and
4, 2013 at the ACC Heart House. Members discussed and refined the
QMs before a final score was obtained from each member of the
expert panel. Candidate metrics were scored for validity and feasibility
on a scale to 1–9, where 9 represented the most valid or most feasible.
To be recommended for “open comment,” a candidate metric required
a mean validity score of 7–9 and a mean feasibility score of 4–9. Con-
sensus among expert panel members was not required for approval
during either round of scoring.
QMs recommended following the RAND-UCLA two-step process
were posted on the ACC website for “open comment” from existing
ACC ACPC members. Comments received during this process were
reviewed and discussed by the Steering Committee and were used to
modify the language of the QM. Final approval of the QMs was deter-
mined by a vote of the ACC ACPC Council.31
3 | RESULTS
3.1 | Literature review
Morbidity and mortality related outcomes post ASO among “simple”
TGA patients are generally quite good.3,12,17 However, patients remain
at risk for arrhythmia. They are also at risk for myocardial ischemia
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secondary to problems that occur during coronary artery transfer and
secondary to more complex coronary artery anatomy as well as to the
translocation process itself.12 Common mid and late-term complica-
tions following ASO include aortic root dilation,15 neoaortic valve
insufficiency, supravalvar stenosis (e.g., aortic and pulmonary), and
branch pulmonary artery stenosis.3 Children who undergo ASO are
also at risk for abnormal ND19 as well as acquired cardiovascular
disease (CVD).25 Finally, transition of care to an adult provider repre-
sents a particularly vulnerable time for the child post ASO, providing an
avenue for poor outcome.33
A formal systematic review was beyond the scope of this project.
However, a thorough review of the existing literature was carried out
to generate candidate metrics. We also searched and reviewed existing
guidelines.2,30,34 Existing guidelines regarding the management of TGA
patients following ASO include the ACC/AHA 2008 Guidelines for the
Management of Adults with CHD34 and a single center study providing
general recommendations for outpatient management post ASO.2
3.2 | Metric #1–#3: Electrocardiogram, Holter
monitoring and exercise stress testing post ASO
The ASO procedure and the translocation of the coronary arteries poses
a potential for immediate as well as mid-term and long-term complica-
tions related to compromised coronary artery perfusion.35 Children with
complex coronary artery anatomy (e.g., intramural course) are at particu-
larly high risk for coronary artery stenosis and subsequent myocardial
ischemia.36 Sudden cardiac death post surgery is rare and has been
reported in 0.3%–0.5% of all TGA/ASO patients.9,37 Children are also at
risk for arrhythmia.6,10,38 However, rates of arrhythmia are low and 98%
of ASO/TGA patients have normal sinus rhythm by Holter monitoring
with occasional premature beats reported in approximately 50%. Rarely
reported are episodes of supraventricular tachycardia or ventricular
tachycardia following ASO.39
Exercise capacity following ASO is typically normal. Exercise test-
ing has been considered useful for detecting exercise induced ischemia
or arrhythmia.40
3.3 | Metric #4–#5: Echocardiogram evaluation
Neoaortic regurgitation (NAR), aortic root dilation (ARD), supravalvar
pulmonary stenosis (SPS), and supravalvar aortic stenosis (SAS) are
commonly reported mid and long-term complications post the ASO
procedure.2,13,17,41,42 NAR occurs early post ASO, is most commonly
mild, but can progress especially among individuals with a history of
size discrepancy between the pulmonary artery and aorta.43 Freedom
from moderate (or more) NAR is 98% at 1 year and 93% at 10 years.42
Aortic root dilation has been reported to occur in at least two-
thirds of TGA/ASO patients42 with a freedom from ARD at 10 years of
51%.42 Furthermore, 10%–15% of TGA/ASO patients develop supra-
valvar pulmonary stenosis by 20 years after ASO.9 Branch pulmonary
artery stenosis is the most frequent reason for reintervention.44
Typically ventricular function post ASO is normal, however, mild
left ventricular dysfunction can develop (e.g., EF 30%–45%) and may
occur secondary to coronary artery stenosis.16 Given these findings,
echocardiographic monitoring has been proposed as a reasonable
method of screening for these complications.
3.4 | Metric #6: Advanced imaging
It was the opinion of the TGA/ASO team that there are times when
echocardiogram images are limited and additional imaging modalities
are necessary to evaluate for the presence of common mid and long
term complications post ASO. Computed tomography (CT),45 magnetic
resonance imaging (MRI) and cardiac catheterization with angiogra-
phy46 were proposed. Studies have shown that CT is a safe and
feasible imaging modality for evaluating the coronary arteries in chil-
dren 5–6 years of age.45 Unfortunately, advanced imaging is costly and
invasive (e.g., coronary angiography) and it remains unclear what
percentage of TGA/ASO patients will ultimately require such testing
for such a recommendation to be considered a QM.
3.5 | Metric #7: ND assessment
The ASO procedure and the circulatory arrest required to carry out the
ASO procedure, places patients at a greater risk of neurocognitive
delay with 27% and 40% greater prevalence of neurologic and speech
impairments among TGA/ASO, respectively.20 Heart surgery per-
formed with circulatory arrest as the predominant support strategy is
associated with a higher risk of delayed motor development and neuro-
logic abnormalities at the age of one year.19 Transient postoperative
seizures following the ASO procedure also place children at greater risk
for worse ND outcomes at ages 1–21=2 years.47 Among children status
post TGA/ASO, weaknesses have been noted in expressive language,
visual-motor integration, motor planning and organization, and oromo-
tor control.21–23 Given the prevalence of these complications, neuro-
cognitive testing was proposed as a QM.
3.6 | Metric #8–#10: Screening for acquired CVD risk
factors
It is well known that children with CHD are at risk for acquired heart
disease, deconditioning and metabolic disease.48 Studies suggest that
children with TGA/ASO do not meet the recommended guidelines for
physical activity49 and many children with CHD have modifiable risk
factors for premature CVD, including diets rich in high fat and sugar
and poor in the recommended intake of fresh fruit, vegetables and lean
meat.50 Furthermore, children who have undergone surgical manipula-
tion of the coronary arteries, such as TGA/ASO patients, have been
shown to have abnormalities in coronary function in later childhood
and may be at increased risk for atherosclerosis as adults.2,25,48 Mea-
surement of body mass index (BMI), blood pressure, and lipid screening
are important and recommended according to existing guidelines.30
3.7 | Metric #11–#12: Transition plan
The AHA currently recommends that all adolescents have a written
transition of care from the pediatric to the adult provider.34 The AAP
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recommends that this transition of care take place between 18 and 21
years of age.29 The TGA/ASO team also recognized the importance of
transition of case as well as reproductive health counselling.28,29,39,51,52
3.8 | Quality metrics
Final recommendations from the TGA/ASO group submitted to the
Steering Committee are shown in Table 1. Twelve QMS were proposed
by the TGA/ASO group (See Supporting Information Appendix 1). Of
the 12 candidate QMs, 7 passed the RAND process and were recom-
mended for review by ACC members during the “open comment
period.” Four QMs passed the “open comment period.”31 Selected
QMs included: (1) the performance of at least 1 echocardiogram during
the first year of life, after ASO, that reports the left ventricular func-
tion, aortic root dimension, the degree of neoaortic valve insufficiency,
and the patency of systemic and pulmonary outflow tracts, the branch
pulmonary arteries and the coronary arteries; (2) ND assessment after
ASO; (3) assessment of lipid profile by age 11 years; and (4) documen-
tation of a transition of care plan to an adult congenital heart disease
(ACHD) provider within the prior 2 years for ASO recipients 18 years
of age or older.
Candidate QMs that did not pass the RAND process included
QMs related to reproductive health counseling, arrhythmia screening,
stress testing and use of additional, more expensive imaging modalities;
these candidate QMs did not pass due to low validity scores (i.e., mean
validity score of 6 during round 1 and mean validity score of 4–5 dur-
ing round 2) and a lack of sufficient evidence. In particular, the follow-
ing QMs did not pass the RAND process: (1) patients after ASO should
be provided with age appropriate reproductive health counseling on
sexual health, contraception, and pregnancy beginning early adoles-
cence; (2) a patient after ASO should undergo periodic electrocardio-
gram (ECGs); (3) a patient after ASO should undergo periodic Holter
monitoring after the ASO; (4) a patient after ASO should have at least
1 stress test by age 11 years; and (5) advanced imaging (MRI, CT, cath)
after ASO between 7 and 11 years of age.
Candidate QMs that passed the RAND process but that were not
ultimately selected by the ACC ACPC Council following the “open
comment period” included: (1) periodic echocardiogram monitoring
beyond infancy following the ASO; (2) a patient after ASO should
undergo regular surveillance of BMI and arterial pressure after ASO;
and (3) provision of information outlining exercise recommendations
after ASO. Although some single center studies suggested echocardio-
grams be performed every 1–2 years following ASO,2 comments
received during the “open comment period” stated that the proposed
frequency of echocardiography after infancy among ASO recipients
was too aggressive. Several comments were received with suggestions
to include additional imaging modalities, beyond echocardiography
alone and a recommendation to decrease the frequency of echocardio-
grams to every 3–5 years. A recommendation for annual visits with the
pediatric cardiologist was also found to be excessive. Although it is rec-
ommended that BMI and BP be assessed yearly among all children,30
not all children following ASO require annual visits with a pediatric
cardiologist. Lipid levels, conversely, can typically be checked much less
frequently and often with a single measurement between 9 and
11 years of age.30 Finally, a recommendation for providing information
outlining exercise recommendations was considered too difficult to
measure as data would be difficult to collect from the EMR.31
4 | DISCUSSION
Since the first ASO procedure in 1975, associated mortality rates have
declined and efforts now focus on ensuring appropriate and data
driven mid-term and long-term follow-up. The current study is timely
and unique in that it identifies methods for improving the care of chil-
dren with TGA/ASO. To date, existing guidelines regarding the man-
agement of individuals with TGA/ASO have focused on adult
TABLE 1 Candidate QM for TGA after ASO submitted to Steering Committee
Candidate measure Numerator Denominator
At least one echo in the first year of life, after ASO
that reports on LV function, aortic root dimen-
sion, degree of aortic insufficiency (AI), patency
of systemic and pulmonary outflows, branch
pulmonary artery stenosis and coronary arteries.
Number of ASO patients reaching their first
birthday for whom at least 1 echocardiogram
has been performed and which documents left
ventricular function, aortic root dimensions,
degree of aortic regurgitation, nature of systemic
and pulmonary outflow tracts and the branch
pulmonary arteries
Number of ASO patients reaching their
first birthday
ND assessment after ASO Number of ASO patients age 24 months or more
who have undergone formal, age-appropriate
ND assessment within the previous 12 months
and the number of patients ages 5–12 years who
have undergone assessment within the previous
24 months
Number of ASO patients reaching the
age of 24 months and the number of
patients between 5 and 12 years
Assessment of lipid profile by age 11 years Number of ASO patients age 11 years who have
undergone assessment of lipid profile within
previous 2 years
Number of ASO patients reaching their
11th birthday
Transition of care: patients with ASO (at age 18 or
greater) with documented transition of care in
the past 2 years
Patients following ASO, age 18 years with a
transition plan documented in the medical
record within the previous 2 years
Number of ASO patients age 18 years
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populations or single center studies.2,34 The QMs created are now
being utilized as a tool for data collection and quality improvement by
30 centers, participating in the Adult Congenital and Pediatric Quality
Network—a national network of CHD centers dedicated to collecting
and sharing data with the goal of providing best practice for CHD
patients.53
Twelve candidate QMs were proposed and 4 were approved. The
approved QMs provide valid and feasible methods for assessing quality
and improving the care of “simple” TGA/ASO patients. The metrics are
not intended to address the highest risk TGA patients, including those
with complex TGA who are more likely to require reintervention or
individuals with variant coronary artery anatomy who are at greatest
risk for arrhythmia and sudden death.54–56
The selected QMs address, however, the most common complica-
tions and risks for poor outcome in the simple TGA/ASO patient popu-
lation. The selected metrics include use of echocardiograms to identify
anatomic problems, followed by identifying risk factors associated with
acquired heart disease (i.e., lipid screening), ND screening and transition
of care. Metrics addressing less common complications, such as
arrhythmia and coronary artery stenosis, were not selected due to lack
of evidence and significantly lower reported rates of such complica-
tions in the non-high risk TGA/ASO population.20 More costly imaging
modalities such as MRI, CT, and angiography were not selected as
these tests may be of low yield in the majority of TGA/ASO patients.57
While not selected, screening BMI and arterial blood pressure
should be performed at all ambulatory care visits regardless of the
presence of TGA/ASO. Furthermore, even though a formal discussion
of reproductive issues was not selected as a metric, it is quite possible
that these discussions take place during the transition process.
Potential challenges with implementation of these metrics include
variations in practice style, preference and limited resource availability.
While echocardiograms are routinely performed and while lipid panels
can be performed in the majority of children, ND and adult congenital
resources may be limited. Future challenges will include not only mak-
ing ND and adult congenital resources more readily available, but iden-
tifying appropriate QM for complex cases of TGA. The current metrics
do not take into consideration special circumstances, such as variant
coronary artery anatomy, the presence of a large VSD or the presence
of risk factors for early mortality including left ventricular outflow tract
obstruction, arrhythmia, weight less than 2.5 kg at time of ASO, or the
need for extracorporeal membrane oxygenation.38
Standardized practices for addressing less critical complications fol-
lowing the ASO are also needed. For example, metrics that address
how best to manage supravalvar stenosis, branch pulmonary artery ste-
nosis and ARD are needed. Future efforts may include a potential role
for biomarkers and the inclusion of studies that address risk stratifica-
tion processes for those at greatest risk of SCD following ASO.
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